Remedy Pharmaceuticals
Latest round
- Series B
Last raised
- May 2012
Total raised
- $3.9M
Investors
- 1
About Remedy Pharmaceuticals
Remedy Pharmaceuticals, Inc.Founded in 2004, Remedy Pharmaceuticals, Inc. is based in New York, US. The company specializes in creating therapeutics, particularly for acute ischemic stroke. In May 2017, Biogen, Inc. acquired Remedy Pharmaceuticals' asset CIRARA for USD 120 mn.Remedy Pharmaceuticals Inc. specializes in the development of innovative therapeutics, with a primary focus on its flagship product, CIRARA, which is designed for the treatment of acute ischemic stroke. CIRARA aims to enhance neurological recovery in patients who have suffered a stroke, utilizing a unique mechanism that targets the underlying pathophysiology of the condition. The company seeks to address critical unmet medical needs by providing effective treatments to healthcare providers and patients navigating the aftermath of a stroke event. Remedy Pharmaceuticals targets healthcare institutions, including hospitals and rehabilitation centers, as its primary clients, while the end-users are the patients who benefit from the therapeutic interventions.Remedy Pharmaceuticals generates revenue primarily through partnerships with healthcare providers and institutions involved in clinical trials and research studies related to its investigational drugs. The transaction structure typically involves agreements with hospitals and research centers that participate in the development and trial phases, allowing for the collection of data and feedback on CIRARA’s efficacy and safety. Revenue generation may be structured through milestone payments contingent on trial progression, as well as potential future licensing agreements following successful regulatory approvals. The company's business model also considers direct to consumer pathways once products receive market authorization, expanding access to its therapeutics.Remedy Pharmaceuticals plans to leverage the recent acquisition of CIRARA by Biogen, Inc. to bolster its presence in the healthcare market. Further product development initiatives are anticipated as the company seeks to enhance its therapeutic offerings.
Who invested in Remedy Pharmaceuticals
1 investor across 4 rounds
See all investors in Remedy Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Remedy Pharmaceuticals
Who invested in Remedy Pharmaceuticals?
Remedy Pharmaceuticals has 1 investor on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Remedy Pharmaceuticals raised?
Remedy Pharmaceuticals has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Remedy Pharmaceuticals last raise money?
Remedy Pharmaceuticals's most recent round on record is a Series B, in May 2012.
What does Remedy Pharmaceuticals do?
Remedy Pharmaceuticals is a pharmaceuticals company.
Where is Remedy Pharmaceuticals headquartered?
Remedy Pharmaceuticals is headquartered in New York, US.
Which VCs invest in companies like Remedy Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Remedy Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series B
Raising like Remedy Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.